| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4) expression
|
Saxena, Ashish
|
|
2013
|
49 |
15 |
p. 3311-3319
9 p.
|
article
|
| 2 |
Analysis of docetaxel therapy in elderly (⩾70years) castration resistant prostate cancer patients enrolled in the Netherlands Prostate Study
|
Gerritse, F.L.
|
|
2013
|
49 |
15 |
p. 3176-3183
8 p.
|
article
|
| 3 |
An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours
|
Schöffski, P.
|
|
2013
|
49 |
15 |
p. 3219-3228
10 p.
|
article
|
| 4 |
A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine
|
Birkhahn, Marc
|
|
2013
|
49 |
15 |
p. 3159-3168
10 p.
|
article
|
| 5 |
Body composition and survival in the early clinical trials setting
|
Veasey Rodrigues, H.
|
|
2013
|
49 |
15 |
p. 3068-3075
8 p.
|
article
|
| 6 |
Cells, sieves, positive and negative attraction: But…slow progress in bladder cancer
|
Raghavan, Derek
|
|
2013
|
49 |
15 |
p. 3065-3067
3 p.
|
article
|
| 7 |
Comments on ‘CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits’, Se-Yeong Oh et al., European Journal of Cancer, published online 6 July 2012
|
Zheng, Shuhua
|
|
2013
|
49 |
15 |
p. 3380-3381
2 p.
|
article
|
| 8 |
Corrigendum to “miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2” [Eur J Cancer 48(16) (2012) 3104–3111]
|
Chen, Lingchao
|
|
2013
|
49 |
15 |
p. 3384-
1 p.
|
article
|
| 9 |
Corrigendum to “Risk of oesophageal adenocarcinoma among individuals born preterm or small for gestational age” [Eur J Cancer 49(9) (2013) 2207–2213]
|
Forssell, Lina
|
|
2013
|
49 |
15 |
p. 3385-
1 p.
|
article
|
| 10 |
Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration
|
Zhang, Yuan
|
|
2013
|
49 |
15 |
p. 3320-3334
15 p.
|
article
|
| 11 |
Diffuse malignant peritoneal mesothelioma: Long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)
|
Baratti, Dario
|
|
2013
|
49 |
15 |
p. 3140-3148
9 p.
|
article
|
| 12 |
Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer
|
Vriens, B.E.P.J.
|
|
2013
|
49 |
15 |
p. 3102-3110
9 p.
|
article
|
| 13 |
Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial
|
Nijkamp, Monique M.
|
|
2013
|
49 |
15 |
p. 3202-3209
8 p.
|
article
|
| 14 |
Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway
|
Lee, Sang Hyuk
|
|
2013
|
49 |
15 |
p. 3210-3218
9 p.
|
article
|
| 15 |
Erratum to: “European Journal of Cancer”, 49(9), 2013, pp. 2077–2276
|
|
|
2013
|
49 |
15 |
p. 3386-
1 p.
|
article
|
| 16 |
Evidence of epidermal growth factor receptor expression in uveal melanoma: Inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity
|
Amaro, Adriana
|
|
2013
|
49 |
15 |
p. 3353-3365
13 p.
|
article
|
| 17 |
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center
|
Wiesweg, Marcel
|
|
2013
|
49 |
15 |
p. 3076-3082
7 p.
|
article
|
| 18 |
Fine mapping of 11q13.5 identifies regions associated with prostate cancer and prostate cancer death
|
Nurminen, Riikka
|
|
2013
|
49 |
15 |
p. 3335-3343
9 p.
|
article
|
| 19 |
High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy
|
Zurrida, S.
|
|
2013
|
49 |
15 |
p. 3083-3092
10 p.
|
article
|
| 20 |
Hormone replacement therapy increases the risk of cranial meningioma
|
Andersen, Lene
|
|
2013
|
49 |
15 |
p. 3303-3310
8 p.
|
article
|
| 21 |
Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch–Belgian Cooperative Trial for Haemato-Oncology (HOVON)
|
Thielen, Noortje
|
|
2013
|
49 |
15 |
p. 3242-3246
5 p.
|
article
|
| 22 |
Impact of the interval between short-course radiotherapy and surgery on outcomes of rectal cancer patients
|
van den Broek, Colette B.M.
|
|
2013
|
49 |
15 |
p. 3131-3139
9 p.
|
article
|
| 23 |
Incidence and mortality of second sarcomas – A population-based study
|
Bjerkehagen, Bodil
|
|
2013
|
49 |
15 |
p. 3292-3302
11 p.
|
article
|
| 24 |
Latent class analysis identifies three subtypes of aggressive end-of-life care: A population-based study in Taiwan
|
Chen, Mei-Ling
|
|
2013
|
49 |
15 |
p. 3284-3291
8 p.
|
article
|
| 25 |
Letter to the editor – Author’s response
|
van de Water, W.
|
|
2013
|
49 |
15 |
p. 3378-3379
2 p.
|
article
|
| 26 |
Local recurrence following breast-conserving treatment in women aged 40years or younger: Trends in risk and the impact on prognosis in a population-based cohort of 1143 patients
|
van Laar, C.
|
|
2013
|
49 |
15 |
p. 3093-3101
9 p.
|
article
|
| 27 |
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after disease progression with other targeted therapies
|
Matrana, M.R.
|
|
2013
|
49 |
15 |
p. 3169-3175
7 p.
|
article
|
| 28 |
Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate data
|
Ronellenfitsch, Ulrich
|
|
2013
|
49 |
15 |
p. 3149-3158
10 p.
|
article
|
| 29 |
Radioembolisation for liver metastases: Results from a prospective 151 patient multi-institutional phase II study
|
Benson III, Al B.
|
|
2013
|
49 |
15 |
p. 3122-3130
9 p.
|
article
|
| 30 |
Recent advances in melanoma systemic therapy. BRAF inhibitors, CTLA4 antibodies and beyond
|
Menzies, Alexander M.
|
|
2013
|
49 |
15 |
p. 3229-3241
13 p.
|
article
|
| 31 |
Response to letter
|
Lim, Young Chang
|
|
2013
|
49 |
15 |
p. 3382-3383
2 p.
|
article
|
| 32 |
Subsequent mortality experience in five-year survivors of childhood, adolescent and young adult cancer in Scotland: A population based, retrospective cohort study
|
Brewster, David H.
|
|
2013
|
49 |
15 |
p. 3274-3283
10 p.
|
article
|
| 33 |
The development of a clinical screening instrument for tumour predisposition syndromes in childhood cancer patients
|
Hopman, Saskia M.J.
|
|
2013
|
49 |
15 |
p. 3247-3254
8 p.
|
article
|
| 34 |
The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid
|
Taylor, F.
|
|
2013
|
49 |
15 |
p. 3184-3190
7 p.
|
article
|
| 35 |
The prognostic impact of tumour-associated macrophages and Reed-Sternberg cells in paediatric Hodgkin lymphoma
|
Gupta, Sumit
|
|
2013
|
49 |
15 |
p. 3255-3261
7 p.
|
article
|
| 36 |
The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo
|
Heffeter, Petra
|
|
2013
|
49 |
15 |
p. 3366-3375
10 p.
|
article
|
| 37 |
Three-arm randomised controlled phase 2 study comparing pemetrexed and erlotinib to either pemetrexed or erlotinib alone as second-line treatment for never-smokers with non-squamous non-small cell lung cancer
|
Lee, Dae Ho
|
|
2013
|
49 |
15 |
p. 3111-3121
11 p.
|
article
|
| 38 |
Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancer
|
Jain, Ajay
|
|
2013
|
49 |
15 |
p. 3344-3352
9 p.
|
article
|
| 39 |
Upfront adjuvant aromatase inhibitors in women with lobular breast cancer
|
Montemurro, Filippo
|
|
2013
|
49 |
15 |
p. 3376-3377
2 p.
|
article
|
| 40 |
Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial
|
van Meurs, Hannah S.
|
|
2013
|
49 |
15 |
p. 3191-3201
11 p.
|
article
|
| 41 |
Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors
|
Vaccarella, Salvatore
|
|
2013
|
49 |
15 |
p. 3262-3273
12 p.
|
article
|
Journal description